GlaxoSmithKline and Sanofi report strong results in trials of Covid vaccine | GlaxoSmithKline | The Guardian

News will offer some some relief for GSK chief Emma Walmsley, who has been under pressure from investor

GlaxoSmithKline vaccine was developed with the French company Sanofi. Photograph: Cezary Kowalski/SOPA Images/Rex/Shutterstock View image in fullscreen GlaxoSmithKline vaccine was developed with the French company Sanofi. Photograph: Cezary Kowalski/SOPA Images/Rex/Shutterstock GSK This article is more than 5 years old GlaxoSmithKline and Sanofi report strong results in trials of Covid vaccine This article is more than 5 years old News will offer some some relief for GSK chief Emma Walmsley, who has been under pressure from investor Coronavirus – latest updates See all our coronavirus coverage

related reading

• 新冠疫苗再添生力軍！賽諾菲/GSK 疫苗二期呈「強烈免疫反應」 | TechNews 科技新報technews.tw
• Company | GSKgsk.com
• The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
• United Kingdom | GSKuk.gsk.com
• GSK and Vir Biotechnology enter collaboration to find coronavirus solutions | GSKgsk.com
• Why we didn't get a malaria vaccine sooner - Works in Progress Magazineworksinprogress.co
• Why were Covid vaccine trials so fast?substack.com
• Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher diseasesanofi.com
• The golden age of vaccine development - Works in Progress Magazineworksinprogress.co
• The story of VaccinateCA - Works in Progress Magazineworksinprogress.co
• The story of mRNA: From a loose idea to a tool that may help curb Covidstatnews.com
• Making Vaccine — LessWronglesswrong.com